Quantum Materials Case Study

Overview

Quantum Materials Corporation (QMC) uniquely merges the physical and the digital worlds on a molecular level by combining QMC Dots with its blockchain-based QMC Platform authenticity technology. The integration of these technologies is creating new services to validate digital identity and authenticate physical products, allowing individuals and organizations to work and live more safely and securely and to transact business with increased trust.

Quantum, founded in San Marcos, Texas in 2007, is known for its open, cloud- delivered, blockchain-based network that ensures authenticity and validation of people, products, and processes.

Its uniquely designed quantum dots utilize nanotechnology and flow reactor manufacturing, and address a number of use cases including counterfeit detection for global brands, verification of individuals’ identity in online business transactions, and health status validation for people who may have been exposed to an infectious disease.

Challenge

With pioneering technology and numerous potential applications, Quantum leadership made a strategic decision to list on NASDAQ, however early estimations were below value expectations. To better position itself for growth, Quantum needed capital support aligned with strategic partners for visibility and expansion into new markets, industries, and geographies.

Pasaca Impact

Pasaca Capital’s controlling investment in Quantum began with financing ongoing software/App development and sourcing leadership hires, such as the COO from their exclusive network. To secure sustainable revenue and profitability to fund growth, Pasaca facilitated a distribution agreement between Quantum and Innova Medical Group, Inc., a wholly owned subsidiary of Pasaca, to begin incorporating Quantum technology into Innova’s ecosystem of COVID-19 testing solutions.

As a result, Quantum secured substantial funding to move forward on major program initiatives. Pasaca also expedited introductions between Quantum and leaders in medical test and device manufacturing, healthcare, technology, media and telecom, transportation, banking sectors, and across the Asia-Pacific region.